Hibit-tagged FLT3 cell line
Ended Purchase Order Awarded Last action
- Contract number
- 75N95C25P00096
- Awardee
-
Editco Bio Inc. UEI MN9PSNE16SJ8
- Awarding agency
-
National Center for Advancing Translational Sciences
National Institutes of Health, Department of Health and Human Services
- Obligated
- $14,857
Award facts
- Contract value 100% obligated
- $14,857.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Redwood City, CA 94063, USA
Award details come from SAM.gov/FPDS.
About this award
Editco Bio Inc., a small disadvantaged business specializing in advanced biomedical research services and cell line generation, was awarded a $14,857 firm fixed-price purchase order by the National Center for Advancing Translational Sciences (NCATS) on September 4, 2025. The contract calls for the delivery of a HIBIT-tagged FLT3 cell line to support scientific research, with performance in Redwood City, California and completion by September 3, 2026. This award carries no set-aside designation and represents a continuation of Editco Bio Inc.'s work providing specialized biological research materials to federal scientific agencies.
NCATS, a component of the National Institutes of Health, funds and supports translational science initiatives that bridge laboratory discoveries and clinical applications. Editco Bio Inc.'s delivery of the HIBIT-tagged FLT3 cell line aligns with NCATS' mission to accelerate biomedical research by providing researchers with precisely engineered cell models. The company has established itself as a reliable vendor for such specialized research materials, having received multiple similar contracts from NCATS and other NIH institutes in recent periods, each involving complex cell line generation and genetic modification services for downstream research and screening applications.
Quick answers
Who was awarded contract 75N95C25P00096?
75N95C25P00096 was awarded to Editco Bio Inc. by National Center for Advancing Translational Sciences (National Institutes of Health) on September 4, 2025.
How much is contract 75N95C25P00096 worth?
The government has obligated $14,857 on 75N95C25P00096.
Was contract 75N95C25P00096 competed?
The extent of competition for 75N95C25P00096 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award